(XCS5) Xtrackers MSCI India Swap - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0514695187 • India Equity
XCS5: Indian, Equities, Stocks, Investments
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar India TME NR USD
Additional Sources for XCS5 ETF
XCS5 ETF Overview
| Market Cap in USD | 134m |
| Category | India Equity |
| TER | 0.61% |
| IPO / Inception | 2010-06-24 |
XCS5 ETF Ratings
| Growth 5y | 69.7% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -16.7 |
| Analysts | - |
| Fair Price Momentum | 18.72 EUR |
| Fair Price DCF | - |
XCS5 Dividends
No Dividends PaidXCS5 Growth Ratios
| Growth Correlation 3m | -30.1% |
| Growth Correlation 12m | 61.1% |
| Growth Correlation 5y | 90.3% |
| CAGR 5y | 11.74% |
| CAGR/Mean DD 5y | 1.61 |
| Sharpe Ratio 12m | 0.13 |
| Alpha | -9.76 |
| Beta | 0.54 |
| Volatility | 18.79% |
| Current Volume | 7.7k |
| Average Volume 20d | 24k |
What is the price of XCS5 stocks?
As of January 30, 2025, the stock is trading at EUR 18.76 with a total of 7,679 shares traded.
Over the past week, the price has changed by -0.46%, over one month by -4.98%, over three months by -6.11% and over the past year by +5.82%.
As of January 30, 2025, the stock is trading at EUR 18.76 with a total of 7,679 shares traded.
Over the past week, the price has changed by -0.46%, over one month by -4.98%, over three months by -6.11% and over the past year by +5.82%.
Is Xtrackers MSCI India Swap a good stock to buy?
Yes. Based on ValueRay Analyses, Xtrackers MSCI India Swap (XETRA:XCS5) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XCS5 as of January 2025 is 18.72. This means that XCS5 is currently overvalued and has a potential downside of -0.21%.
Yes. Based on ValueRay Analyses, Xtrackers MSCI India Swap (XETRA:XCS5) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XCS5 as of January 2025 is 18.72. This means that XCS5 is currently overvalued and has a potential downside of -0.21%.
Is XCS5 a buy, sell or hold?
Xtrackers MSCI India Swap has no consensus analysts rating.
Xtrackers MSCI India Swap has no consensus analysts rating.
What are the forecast for XCS5 stock price target?
According to ValueRays Forecast Model, XCS5 Xtrackers MSCI India Swap will be worth about 20.5 in January 2026. The stock is currently trading at 18.76. This means that the stock has a potential upside of +9.28%.
According to ValueRays Forecast Model, XCS5 Xtrackers MSCI India Swap will be worth about 20.5 in January 2026. The stock is currently trading at 18.76. This means that the stock has a potential upside of +9.28%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 20.5 | 9.3% |